JPMorgan analyst Anupam Rama upgraded AnaptysBio (NASDAQ: ANAB) from Neutral to Overweight with a price target of $69.00 (from $29.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE